本、硕、博毕业于北京大学临床药学专业,长期从事医院药事管理及合理用药相关工作,作为临床药师在神经精神系统疾病、呼吸慢病领域开展医、教、研工作,并围绕中药有效成分进行药效评价及新制剂开发研究。承担/参与国家重点研发计划、国家科技重大专项重大新药创制、国自然、自治区重点研发计划等课题多项,参与新药临床试验10余项,以一作或通讯作者发表SCI/核心期刊近20篇。
中国老年医学学会药事管理与药学服务分会委员
中国人体健康科技促进会智慧药学专业委员会副秘书长
中国药理学会治疗药物监测委员会临床药师学组副组长
北京药学会精神药物治疗与管理专业委员会副主任委员
北京医师协会临床药师分会常务理事
北京药理学会精准药学专业委员会委员
1.Sun K, Li Y, Wu F, Tian H, Fang M, Zhao X, Wang G*, Cui Y*. Effects of CYP2D6, CYP3A5, and ABCB1 gene polymorphisms on the pharmacokinetics of two risperidone long-acting injection microsphere formulations. Prog Neuropsychopharmacol Biol Psychiatry. 2021, 109:110241.
2.Fu L, Dong S, Xie R, Jia G, Zhao N, Xiang Q, Ji X, Zhao X, Chen X, Ma L*, Cui Y*. A multi-dimensional comparative study of 505(b)(2) NDAs approved by FDA and Class 2 NDAs approved by NMPA from 2017 to 2023: Uncovering trends, characteristics, and regulation of modified new drugs. Regul Toxicol Pharmacol. 2025,162:105864. Epub ahead of print
3.Ma L, Xiang Q, Zhou S, Tan Y, Zhang X, Yang T, Xie Q, Mu G, Zhao X, Zhou Y, Li S*, Cui Y*. Association of dopamine D2 receptor gene polymorphisms with prolactin levels related to risperidone treatment: A systematic review and meta-analysis. J Clin Pharm Ther. 2019 Aug;44(4):543-552.
4.Ma L, Zhang X, Xiang Q, Zhou S, Zhao N, Xie Q, Zhao X, Zhou Y, Cui Y*. Association between dopamine receptor gene polymorphisms and effects of risperidone treatment: A systematic review and meta-analysis. Basic Clin Pharmacol Toxicol. 2019 Jan;124(1):94-104.
5.Jiayu Cai, Yang Liu, Lu Zhang, Rui-bo Guo, Yang Liu, Xuetao Li, Lingyue Ma*, Liang Kong*. Menthol-modified paclitaxel multifunctional cationic liposomes cross the blood-brain barrier and target glioma stem cells for treatment of glioblastoma, Journal of Drug Delivery Science and Technology, 2024, 93: 105387
6.Gong J#, Ma L#, Li M, Ma L, Chen C, Zhao S, Zhou Y, Cui Y*. Nonsteroidal anti-inflammatory drugs associated acute kidney injury in hospitalized children: A systematic review and meta-analysis. Pharmacoepidemiol Drug Saf. 2022,31(2):117-127.
7.Liu Z#, Ma L#, Zhang H, Mu G, Xie Q, Zhou S, Wang Z, Wang Z, Hu K, Gong Y, Jiang J, Xiang Q*, Cui Y*. Comparison of non-vitamin K antagonist oral anticoagulants on bleeding and thrombosis. J Clin Pharm Ther. 2021 Dec;46(6):1729-1742.
8.杜雨蒙,杨思敏,秦小桐,李妍,居瑞军,彭效明,严晓强,管洁,马凌悦*.淫羊藿苷对神经元细胞氧化应激损伤的保护作用及机制研究[J].中国临床药理学杂志,2024,40(13):1869-1873.
9.马凌悦,陈松,李安宁,赵楠,向倩,赵侠,崔一民.我国精神障碍药物临床试验研发现状的调查分析[J]. 中国临床药理学杂志, 2022, 38(05):460-464.
10.马凌悦,向倩,周颖,崔一民. 心境障碍及其治疗与生物节律相关性的研究现状[J]. 中国临床药理学杂志,2019,35(14):1533-1536.